HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katharine C Lai Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

1/2019The novel CD19-targeting antibody-drug conjugate huB4-DGN462 shows improved anti-tumor activity compared to SAR3419 in CD19-positive lymphoma and leukemia models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katharine C Lai Research Topics

Disease

9Neoplasms (Cancer)
01/2021 - 03/2010
2Lymphoma (Lymphomas)
01/2019 - 11/2013
2Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2017 - 11/2013
1Colorectal Neoplasms (Colorectal Cancer)
10/2020
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019
1Leukemia
01/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2019
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2017
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2013
1Colonic Neoplasms (Colon Cancer)
04/2011

Drug/Important Bio-Agent (IBA)

6Immunoconjugates (Immunoconjugate)IBA
01/2021 - 11/2013
3AntigensIBA
01/2021 - 03/2010
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2018
2Rituximab (Mabthera)FDA Link
09/2017 - 11/2013
2naratuximab emtansineIBA
09/2017 - 11/2013
1auristatinIBA
10/2020
1indusatumabIBA
10/2020
1coltuximab ravtansineIBA
01/2019
1Cytotoxins (Cytolysins)IBA
01/2018
1Alkylating AgentsIBA
01/2018
1Differentiation AntigensIBA
01/2018
1Peptides (Polypeptides)IBA
01/2016
1Epithelial Cell Adhesion MoleculeIBA
01/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2013
1Bendamustine HydrochlorideFDA Link
11/2013
1Prednisone (Sone)FDA LinkGeneric
11/2013
1Vincristine (Oncovin)FDA LinkGeneric
11/2013
1DisulfidesIBA
04/2011
1AntibodiesIBA
03/2010

Therapy/Procedure

1Intravenous Administration
10/2020